Methanol Chemicals Company (2001) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Reported net loss of SAR 286.2 million for 2024, with current liabilities exceeding current assets by SAR 168.5 million, raising material uncertainty about going concern; management plans a rights issue and loan restructuring in 2025 to address liquidity.
Revenue declined to SAR 710.5 million in 2024 from SAR 728.0 million in 2023, mainly due to lower product prices and industry headwinds.
Two major acquisitions completed: Addar Chemicals Company (84%) and Global Company for Chemical Industries (80%), expanding product range but resulting in significant goodwill impairment.
Financial highlights
Revenue: SAR 710.5 million in 2024, down 2.4% year-over-year.
Net loss: SAR 286.2 million in 2024, compared to SAR 177.8 million loss in 2023.
Gross profit: SAR 96.2 million in 2024, up from SAR 9.4 million in 2023, driven by lower cost of sales.
Impairment losses: SAR 2.0 million on property, plant, and equipment and SAR 127.0 million on goodwill in 2024.
Basic and diluted loss per share: SAR (4.04) in 2024 vs. SAR (2.64) in 2023.
Outlook and guidance
Management expects to complete a rights issue in 2025 to improve liquidity and address going concern risks.
Ongoing discussions with lenders for restructuring and/or rescheduling of subsidiary loans; cost-reduction and operational efficiency measures underway.
Latest events from Methanol Chemicals Company
- Net loss of SAR 570 million, major impairments, and urgent capital actions amid going concern risks.2001
Q3 202526 Nov 2025 - H1 2025 saw a SR 529.3 million net loss and major impairment, raising going concern risks.2001
Q2 202518 Aug 2025 - Net loss narrowed to SAR 81.98m as two major acquisitions were consolidated.2001
Q3 202413 Jun 2025 - Net loss narrowed and two key acquisitions completed, with gross profit up despite lower revenue.2001
Q2 202413 Jun 2025 - Net loss deepened and liquidity risks persist as Chemanol pursues a major rights issue.2001
Q1 20256 Jun 2025